GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
28 Feb 2003 12:51 PM
RNS
Director Shareholding
27 Feb 2003 05:04 PM
RNS
Purchase of Own Securities
27 Feb 2003 03:32 PM
RNS
Director Shareholding
26 Feb 2003 05:21 PM
RNS
Director Shareholding
26 Feb 2003 03:23 PM
RNS
Director Shareholding
25 Feb 2003 05:03 PM
RNS
Purchase of Own Securities
24 Feb 2003 06:14 PM
RNS
Director Shareholding
24 Feb 2003 06:07 PM
RNS
Director Shareholding
24 Feb 2003 05:09 PM
RNS
Purchase of Own Securities
24 Feb 2003 04:22 PM
RNS
Director Shareholding
21 Feb 2003 05:01 PM
RNS
Purchase of Own Securities
21 Feb 2003 04:33 PM
RNS
Holding(s) in Company
19 Feb 2003 04:55 PM
RNS
Purchase of Own Securities
18 Feb 2003 04:58 PM
RNS
Purchase of Own Securities
17 Feb 2003 04:59 PM
RNS
Director Shareholding
17 Feb 2003 04:57 PM
RNS
Director Shareholding
17 Feb 2003 03:15 PM
RNS
Director Shareholding
14 Feb 2003 05:09 PM
RNS
Director Shareholding
13 Feb 2003 04:55 PM
RNS
Purchase of Own Securities
13 Feb 2003 12:10 PM
RNS
Director Shareholding
12 Feb 2003 12:00 PM
RNS
Final Results
10 Feb 2003 03:40 PM
RNS
Directorate Change
10 Feb 2003 01:48 PM
RNS
Director Shareholding
07 Feb 2003 03:39 PM
RNS
Director Shareholding
03 Feb 2003 05:43 PM
RNS
Director Shareholding
03 Feb 2003 05:41 PM
RNS
Director Shareholding
03 Feb 2003 04:33 PM
RNS
Director Shareholding
03 Feb 2003 04:22 PM
RNS
Director Shareholding
28 Jan 2003 03:21 PM
RNS
Director Shareholding
27 Jan 2003 04:28 PM
RNS
Director Shareholding-Replace
27 Jan 2003 02:43 PM
RNS
Blocklisting Interim Review
27 Jan 2003 02:20 PM
RNS
Director Shareholding
23 Jan 2003 05:39 PM
RNS
Positive Opinion - Seretide
21 Jan 2003 12:50 PM
RNS
Director Shareholding
21 Jan 2003 10:02 AM
RNS
Director Shareholding
21 Jan 2003 09:58 AM
RNS
Director Shareholding
17 Jan 2003 03:25 PM
RNS
Director Shareholding
15 Jan 2003 07:00 AM
RNS
Paxil Litigation Update
13 Jan 2003 04:57 PM
RNS
Director Shareholding
13 Jan 2003 12:04 PM
RNS
Director Shareholding
10 Jan 2003 03:09 PM
RNS
Director Shareholding
10 Jan 2003 03:04 PM
RNS
Director Shareholding
08 Jan 2003 05:23 PM
RNS
Director Shareholding
08 Jan 2003 04:39 PM
RNS
Director Shareholding
07 Jan 2003 03:51 PM
RNS
Director Shareholding
07 Jan 2003 03:49 PM
RNS
Director Shareholding
07 Jan 2003 03:43 PM
RNS
Director Shareholding
07 Jan 2003 11:14 AM
RNS
Director Shareholding
06 Jan 2003 05:31 PM
RNS
Director Shareholding
06 Jan 2003 04:30 PM
RNS
Director Shareholding

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings